The persistent challenge of encouraging public participation in the low-carbon transition

By Peters Michael   Fudge Shane   Hoffman Steven M  

Carbon Management, Vol. 4, Iss. 4, 2013-08 ,pp. : 373-375

Future Science

Access to resources Recommend Favorite

Exploratory assessment of the current EU regulatory framework for development of advanced therapies

By Singh Pawanbir   Brévignon-Dodin Laure   Dash Satya P  

Journal of Commercial Biotechnology, Vol. 16, Iss. 4, 2010-10 ,pp. : 331-336

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Fat media-hype greets obesity genes: is industry among the potential losers?

By Rothenberg L.  

Trends in Biotechnology, Vol. 14, Iss. 2, 1996-02 ,pp. : 35-37

Elsevier

Access to resources Recommend Favorite

A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on pharmacovigilance

By Ladds Graeme  

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 44-53

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

EU Legal and Regulatory Update

By  

Journal of Commercial Biotechnology, Vol. 17, Iss. 2, 2011-05 ,pp. : 183-189

Palgrave Macmillan Ltd

Access to resources Recommend Favorite